Back to Resources

SCORR Marketing and Applied Clinical Trials conducted a survey to gather information to evaluate the trends for global clinical trials in China and the reasons behind the decisions to conduct — or not to conduct — clinical trials in that country.

IN THIS SURVEY, INFORMATION WAS GATHERED ON:

  • How many companies conduct trials in China and why
  • Therapeutic areas most likely to be the focus of trials in China
  • The effects of Chinese regulations to combat corruption and align procedures with good clinical practices
  • Whether companies conducting trials in China prefer to partner with a Chinese company or establish their own presence
  • Regions that will see more and fewer clinical trials in five years